Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Seeman

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Journal of Neurochemistry|April 12, 2006
Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomographyNathalie Ginovart, Laurent Galineau, Matthaeus Willeit, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 6, 2006
Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaineJesse R Schank, Rossella Ventura, Stefano Puglisi-Allegra, et al.
Neuroreport|May 9, 2002
Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic actionShitij Kapur, Robert A McClelland, Susan C VanderSpek, et al.
The Journal of Biological Chemistry|September 25, 2010
The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophreniaMelissa L Perreault, Ahmed Hasbi, Mohammed Alijaniaram, et al.
Human Brain Mapping|May 15, 2007
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humansAriel Graff-Guerrero, Matthaeus Willeit, Nathalie Ginovart, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2003
Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivoSusan R George, Gordon Y K Ng, Samuel P Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2014
(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET StudySjoerd J Finnema, Vladimir Stepanov, Ryuji Nakao, et al.
Synapse (New York, N.Y.)|June 21, 2006
Psychosis pathways converge via D2high dopamine receptorsPhilip Seeman, Johannes Schwarz, Jiang-Fan Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2005
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosisPhilip Seeman, David Weinshenker, Remi Quirion, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Journal of Neurochemistry|April 12, 2006
Binding characteristics and sensitivity to endogenous dopamine of [11C]-(+)-PHNO, a new agonist radiotracer for imaging the high-affinity state of D2 receptors in vivo using positron emission tomographyNathalie Ginovart, Laurent Galineau, Matthaeus Willeit, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 6, 2006
Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaineJesse R Schank, Rossella Ventura, Stefano Puglisi-Allegra, et al.
Neuroreport|May 9, 2002
Increasing D2 affinity results in the loss of clozapine's atypical antipsychotic actionShitij Kapur, Robert A McClelland, Susan C VanderSpek, et al.
The Journal of Biological Chemistry|September 25, 2010
The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophreniaMelissa L Perreault, Ahmed Hasbi, Mohammed Alijaniaram, et al.
Human Brain Mapping|May 15, 2007
Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humansAriel Graff-Guerrero, Matthaeus Willeit, Nathalie Ginovart, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 13, 2003
Blockade of G protein-coupled receptors and the dopamine transporter by a transmembrane domain peptide: novel strategy for functional inhibition of membrane proteins in vivoSusan R George, Gordon Y K Ng, Samuel P Lee, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 3, 2014
(18)F-MCL-524, an (18)F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET StudySjoerd J Finnema, Vladimir Stepanov, Ryuji Nakao, et al.
Synapse (New York, N.Y.)|June 21, 2006
Psychosis pathways converge via D2high dopamine receptorsPhilip Seeman, Johannes Schwarz, Jiang-Fan Chen, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 18, 2005
Dopamine supersensitivity correlates with D2High states, implying many paths to psychosisPhilip Seeman, David Weinshenker, Remi Quirion, et al.
Pageof 9